Anavex Life Sciences Corporation

NASDAQ:AVXL   4:00:00 PM EDT
8.38
-1.20 (-12.53%)
7:56:58 PM EDT: $8.39 +0.01 (+0.12%)
Products

Anavex Announces U.S. FDA Orphan Drug Tag For Its Fragile X Syndrome Treatment

Published: 11/07/2022 12:59 GMT
Anavex Life Sciences Corporation (AVXL) - Anavex Announces U.S. FDA Orphan Drug Designation to Anavex®2-73 (blarcamesine) for the Treatment of Fragile X Syndrome.